Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDYA | VRDN | ARQT | ||
| Company | Ideaya Biosciences Inc | Viridian Therapeutics Inc | Arcutis Biotherapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 32.73 | 27.62 | 22.92 | ||
| High | 32.91 | 28.30 | 23.46 | ||
| Low | 30.20 | 27.25 | 22.12 | ||
| Latest | 31.64 | 27.62 | 22.29 | ||
| Change | -1.11 | +0.64 | +0.08 | ||
| % Change | -3.39% | +2.37% | +0.36% | ||
| Volume | 2,005,300 | 1,655,100 | 1,034,200 | ||
| 20-Day Average Volume | 960,335 | 1,398,845 | 1,564,705 | ||
| Previous Close | 32.75 | 26.98 | 22.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.26 | 28.82 | 24.21 | ||
| 20-Day Raw Stochastic | 26.28% | 29.24% | 6.20% | ||
| 20-Day Relative Strength | 44.46 | 42.80 | 38.62 | ||
| Weighted Alpha | +70.40 | +82.17 | +29.20 | ||
| Today's Opinion | Hold | 8% Buy | 24% Sell | ||
| Previous Opinion | 24% Buy | 8% Buy | 24% Sell | ||
| Last Month's Opinion | 24% Buy | 24% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.05% since 03/16/26 | -4.00% since 03/16/26 | -2.07% since 03/16/26 | ||
| Low | 30.20 on 03/23/26 | 26.95 on 03/20/26 | 21.86 on 03/19/26 | ||
| High | 35.26 on 03/17/26 | 29.32 on 03/17/26 | 23.46 on 03/23/26 | ||
| 1-Month | |||||
| %Chg | -1.46% since 02/23/26 | -1.60% since 02/23/26 | -15.28% since 02/23/26 | ||
| Low | 30.20 on 03/23/26 | 26.31 on 02/26/26 | 21.86 on 03/19/26 | ||
| High | 35.68 on 03/03/26 | 30.79 on 03/05/26 | 28.80 on 02/26/26 | ||
| 3-Month | |||||
| %Chg | -10.65% since 12/23/25 | -13.98% since 12/23/25 | -23.95% since 12/23/25 | ||
| Low | 29.47 on 02/17/26 | 26.31 on 02/26/26 | 21.86 on 03/19/26 | ||
| High | 39.28 on 01/07/26 | 34.29 on 01/14/26 | 30.75 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +22.02% since 09/23/25 | +41.21% since 09/23/25 | +26.65% since 09/23/25 | ||
| Low | 25.35 on 09/25/25 | 18.86 on 09/25/25 | 16.57 on 09/25/25 | ||
| High | 39.28 on 01/07/26 | 34.29 on 01/14/26 | 31.77 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,778,435 | 2,822,958 | 2,764,695 | ||
| Shares Outstanding, K | 87,814 | 102,207 | 124,033 | ||
| Annual Sales | 218,710,000 | 70,850,000 | 376,070,000 | ||
| Annual Net Income | -113,700,000 | -342,600,000 | -16,140,000 | ||
| Last Quarter Sales | 10,880,000 | 130,000 | 129,500,000 | ||
| Last Quarter Net Income | -83,270,000 | -120,360,000 | 17,400,000 | ||
| 60-Month Beta | 0.09 | 1.00 | 1.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.94 on 02/17/26 | -1.08 on 02/26/26 | 0.13 on 02/25/26 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||